Performance Evaluation of BD FACSPresto<sup>TM</sup> Near-Patient CD4 Counter for Monitoring Antiretroviral Therapy in HIV-Infected Individuals in Primary Healthcare Clinics in Thailand

HIV viral load is more reliable tool for monitoring treatment throughout the course of HIV/AIDS, but the test may be expensive in resource-limited settings. Therefore, enumeration of CD4 T-lymphocyte count remains important in these settings. This study evaluated the performance of BDFACSPresto, a n...

Full description

Bibliographic Details
Main Authors: Kasama Sukapirom, Somrat Matchua, Charin Thepthai, Narinee Srimark, Ladawan Khowawisetsut, Kovit Pattanapanyasat
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/2/382
_version_ 1797481194110058496
author Kasama Sukapirom
Somrat Matchua
Charin Thepthai
Narinee Srimark
Ladawan Khowawisetsut
Kovit Pattanapanyasat
author_facet Kasama Sukapirom
Somrat Matchua
Charin Thepthai
Narinee Srimark
Ladawan Khowawisetsut
Kovit Pattanapanyasat
author_sort Kasama Sukapirom
collection DOAJ
description HIV viral load is more reliable tool for monitoring treatment throughout the course of HIV/AIDS, but the test may be expensive in resource-limited settings. Therefore, enumeration of CD4 T-lymphocyte count remains important in these settings. This study evaluated the performance of BDFACSPresto, a near-patient CD4 counter planned to be used in primary healthcare clinics in Thailand. Results of percent, absolute CD4 count and hemoglobin (Hb) on the FACSPresto were compared with the TriTEST/TruCOUNT/BDFACSCalibur method and a Sysmex hematology analyzer. Phase I of the study was performed in an ISO15189 laboratory. Both percentage and absolute values showed Passing–Bablok slopes within 0.98–1.06 and 0.97–1.13, mean Bland–Altman biases of +1.2% and +20.5 cells/µL, respectively. In phase II, venous and some capillary blood samples were analyzed in four primary healthcare clinics. The results showed good correlation between capillary and venous blood. For venous blood samples, regression lines showed slopes of 1.01–1.05 and 1.01–1.07 for all percentage and absolute values. The overall mean biases were +0.9% and +17.0 cells/µL. For Hb, Passing–Bablok regression result gave slope within 1.01–1.07 and mean bias of −0.06 g/dL. Thus, CD4 enumeration in blood by the FACSPresto is reliable and can be performed to an identical standard at primary healthcare clinics.
first_indexed 2024-03-09T22:11:01Z
format Article
id doaj.art-0eb62a7b0dd34a4e9388c675d2001bcd
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T22:11:01Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-0eb62a7b0dd34a4e9388c675d2001bcd2023-11-23T19:31:08ZengMDPI AGDiagnostics2075-44182022-02-0112238210.3390/diagnostics12020382Performance Evaluation of BD FACSPresto<sup>TM</sup> Near-Patient CD4 Counter for Monitoring Antiretroviral Therapy in HIV-Infected Individuals in Primary Healthcare Clinics in ThailandKasama Sukapirom0Somrat Matchua1Charin Thepthai2Narinee Srimark3Ladawan Khowawisetsut4Kovit Pattanapanyasat5Siriraj Center of Research Excellence in Microparticle and Exosome in Diseases, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, ThailandDepartment of Medical Technology, Chonburi Hospital, Chonburi 20000, ThailandDepartment of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, ThailandSiriraj Center of Research Excellence in Microparticle and Exosome in Diseases, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, ThailandDepartment of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, ThailandSiriraj Center of Research Excellence in Microparticle and Exosome in Diseases, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, ThailandHIV viral load is more reliable tool for monitoring treatment throughout the course of HIV/AIDS, but the test may be expensive in resource-limited settings. Therefore, enumeration of CD4 T-lymphocyte count remains important in these settings. This study evaluated the performance of BDFACSPresto, a near-patient CD4 counter planned to be used in primary healthcare clinics in Thailand. Results of percent, absolute CD4 count and hemoglobin (Hb) on the FACSPresto were compared with the TriTEST/TruCOUNT/BDFACSCalibur method and a Sysmex hematology analyzer. Phase I of the study was performed in an ISO15189 laboratory. Both percentage and absolute values showed Passing–Bablok slopes within 0.98–1.06 and 0.97–1.13, mean Bland–Altman biases of +1.2% and +20.5 cells/µL, respectively. In phase II, venous and some capillary blood samples were analyzed in four primary healthcare clinics. The results showed good correlation between capillary and venous blood. For venous blood samples, regression lines showed slopes of 1.01–1.05 and 1.01–1.07 for all percentage and absolute values. The overall mean biases were +0.9% and +17.0 cells/µL. For Hb, Passing–Bablok regression result gave slope within 1.01–1.07 and mean bias of −0.06 g/dL. Thus, CD4 enumeration in blood by the FACSPresto is reliable and can be performed to an identical standard at primary healthcare clinics.https://www.mdpi.com/2075-4418/12/2/382AIDSCD4FACSPrestoflow cytometryHIVpoint-of-care testing
spellingShingle Kasama Sukapirom
Somrat Matchua
Charin Thepthai
Narinee Srimark
Ladawan Khowawisetsut
Kovit Pattanapanyasat
Performance Evaluation of BD FACSPresto<sup>TM</sup> Near-Patient CD4 Counter for Monitoring Antiretroviral Therapy in HIV-Infected Individuals in Primary Healthcare Clinics in Thailand
Diagnostics
AIDS
CD4
FACSPresto
flow cytometry
HIV
point-of-care testing
title Performance Evaluation of BD FACSPresto<sup>TM</sup> Near-Patient CD4 Counter for Monitoring Antiretroviral Therapy in HIV-Infected Individuals in Primary Healthcare Clinics in Thailand
title_full Performance Evaluation of BD FACSPresto<sup>TM</sup> Near-Patient CD4 Counter for Monitoring Antiretroviral Therapy in HIV-Infected Individuals in Primary Healthcare Clinics in Thailand
title_fullStr Performance Evaluation of BD FACSPresto<sup>TM</sup> Near-Patient CD4 Counter for Monitoring Antiretroviral Therapy in HIV-Infected Individuals in Primary Healthcare Clinics in Thailand
title_full_unstemmed Performance Evaluation of BD FACSPresto<sup>TM</sup> Near-Patient CD4 Counter for Monitoring Antiretroviral Therapy in HIV-Infected Individuals in Primary Healthcare Clinics in Thailand
title_short Performance Evaluation of BD FACSPresto<sup>TM</sup> Near-Patient CD4 Counter for Monitoring Antiretroviral Therapy in HIV-Infected Individuals in Primary Healthcare Clinics in Thailand
title_sort performance evaluation of bd facspresto sup tm sup near patient cd4 counter for monitoring antiretroviral therapy in hiv infected individuals in primary healthcare clinics in thailand
topic AIDS
CD4
FACSPresto
flow cytometry
HIV
point-of-care testing
url https://www.mdpi.com/2075-4418/12/2/382
work_keys_str_mv AT kasamasukapirom performanceevaluationofbdfacsprestosuptmsupnearpatientcd4counterformonitoringantiretroviraltherapyinhivinfectedindividualsinprimaryhealthcareclinicsinthailand
AT somratmatchua performanceevaluationofbdfacsprestosuptmsupnearpatientcd4counterformonitoringantiretroviraltherapyinhivinfectedindividualsinprimaryhealthcareclinicsinthailand
AT charinthepthai performanceevaluationofbdfacsprestosuptmsupnearpatientcd4counterformonitoringantiretroviraltherapyinhivinfectedindividualsinprimaryhealthcareclinicsinthailand
AT narineesrimark performanceevaluationofbdfacsprestosuptmsupnearpatientcd4counterformonitoringantiretroviraltherapyinhivinfectedindividualsinprimaryhealthcareclinicsinthailand
AT ladawankhowawisetsut performanceevaluationofbdfacsprestosuptmsupnearpatientcd4counterformonitoringantiretroviraltherapyinhivinfectedindividualsinprimaryhealthcareclinicsinthailand
AT kovitpattanapanyasat performanceevaluationofbdfacsprestosuptmsupnearpatientcd4counterformonitoringantiretroviraltherapyinhivinfectedindividualsinprimaryhealthcareclinicsinthailand